Aclaris Therapeutics, Inc. (LON:0H8T)
1.940
-0.085 (-4.20%)
At close: Sep 12, 2025
Aclaris Therapeutics Employees
As of December 31, 2024, Aclaris Therapeutics had 64 total employees, including 61 full-time and 3 part-time employees. The number of employees decreased by 27 or -29.67% compared to the previous year.
Employees
64
Change (1Y)
-27
Growth (1Y)
-29.67%
Revenue / Employee
194.51K GBP
Profits / Employee
-1.56M GBP
Market Cap
143.52M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 64 | -27 | -29.67% |
Dec 31, 2023 | 91 | -14 | -13.33% |
Dec 31, 2022 | 105 | 28 | 36.36% |
Dec 31, 2021 | 77 | 17 | 28.33% |
Dec 31, 2020 | 60 | -17 | -22.08% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 94,300 |
GSK plc | 68,629 |
Haleon | 24,561 |
Smith & Nephew | 17,349 |
ConvaTec Group | 10,489 |
Hikma Pharmaceuticals | 9,500 |
HUTCHMED (China) | 1,811 |
Genus | 3,500 |
Aclaris Therapeutics News
- 9 days ago - Aclaris Therapeutics Announces Late-Breaking Abstract and Oral Presentation On ATI-2138 Phase 2a Results at the 2025 European Academy of Dermatology and Venereology (EADV) Congress - GlobeNewsWire
- 22 days ago - Aclaris Therapeutics to Participate in Two September Healthcare Conferences - GlobeNewsWire
- 6 weeks ago - Aclaris Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 7 weeks ago - Aclaris Therapeutics Stock Spikes In After‑Hours Session Following Major Announcement - Benzinga
- 7 weeks ago - Aclaris Therapeutics Announces Positive Top-Line Results from Open-Label Phase 2a Trial of ATI-2138, a Potent and Selective Investigational Inhibitor of ITK and JAK3; Trial Achieves Primary and Key Secondary Endpoints - GlobeNewsWire
- 7 weeks ago - Aclaris Therapeutics Announces Leadership Transition - GlobeNewsWire
- 2 months ago - Aclaris Therapeutics joins Russell 3000 and Russell 2000 Indexes - Seeking Alpha
- 2 months ago - Aclaris Therapeutics Added to the Russell 2000® and Russell 3000® Indexes - GlobeNewsWire